Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

High avidity myeloid leukemia-associated antigen-specific CD8+ T cells preferentially reside in the bone marrow.

Melenhorst JJ, Scheinberg P, Chattopadhyay PK, Gostick E, Ladell K, Roederer M, Hensel NF, Douek DC, Barrett AJ, Price DA.

Blood. 2009 Mar 5;113(10):2238-44. doi: 10.1182/blood-2008-04-151969. Epub 2008 Nov 7.

2.

Longitudinal analyses of leukemia-associated antigen-specific CD8+ T cells in patients after allogeneic stem cell transplantation.

Rücker-Braun E, Link CS, Schmiedgen M, Tunger A, Vizjak P, Teipel R, Wehner R, Kühn D, Fuchs YF, Oelschlägel U, Germeroth L, Schmitz M, Bornhäuser M, Schetelig J, Heidenreich F.

Exp Hematol. 2016 Nov;44(11):1024-1033.e1. doi: 10.1016/j.exphem.2016.07.008. Epub 2016 Jul 26.

PMID:
27473564
3.

Functional unresponsiveness and replicative senescence of myeloid leukemia antigen-specific CD8+ T cells after allogeneic stem cell transplantation.

Beatty GL, Smith JS, Reshef R, Patel KP, Colligon TA, Vance BA, Frey NV, Johnson FB, Porter DL, Vonderheide RH.

Clin Cancer Res. 2009 Aug 1;15(15):4944-53. doi: 10.1158/1078-0432.CCR-08-3332. Epub 2009 Jul 14.

4.

Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.

Tan LC, Mowat AG, Fazou C, Rostron T, Roskell H, Dunbar PR, Tournay C, Romagné F, Peyrat MA, Houssaint E, Bonneville M, Rickinson AB, McMichael AJ, Callan MF.

Arthritis Res. 2000;2(2):154-64. Epub 2000 Feb 7.

5.

Characterization of cytotoxic function of CMV-pp65-specific CD8+ T-lymphocytes identified by HLA tetramers in recipients and donors of stem-cell transplants.

Lacey SF, Gallez-Hawkins G, Crooks M, Martinez J, Senitzer D, Forman SJ, Spielberger R, Zaia JA, Diamond DJ.

Transplantation. 2002 Sep 15;74(5):722-32.

PMID:
12352893
6.

Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes.

Faber LM, van der Hoeven J, Goulmy E, Hooftman-den Otter AL, van Luxemburg-Heijs SA, Willemze R, Falkenburg JH.

J Clin Invest. 1995 Aug;96(2):877-83.

7.

T-cell responses directed against multiple HLA-A*0201-restricted epitopes derived from Wilms' tumor 1 protein in patients with leukemia and healthy donors: identification, quantification, and characterization.

Rezvani K, Brenchley JM, Price DA, Kilical Y, Gostick E, Sewell AK, Li J, Mielke S, Douek DC, Barrett AJ.

Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8799-807.

8.

Detection of low avidity CD8(+) T cell populations with coreceptor-enhanced peptide-major histocompatibility complex class I tetramers.

Melenhorst JJ, Scheinberg P, Chattopadhyay PK, Lissina A, Gostick E, Cole DK, Wooldridge L, van den Berg HA, Bornstein E, Hensel NF, Douek DC, Roederer M, Sewell AK, Barrett AJ, Price DA.

J Immunol Methods. 2008 Sep 30;338(1-2):31-9. doi: 10.1016/j.jim.2008.07.008. Epub 2008 Jul 31.

9.

Characterization of CMVpp65-specific CD8+ T lymphocytes using MHC tetramers in kidney transplant patients and healthy participants.

Engstrand M, Tournay C, Peyrat MA, Eriksson BM, Wadström J, Wirgart BZ, Romagné F, Bonneville M, Tötterman TH, Korsgren O.

Transplantation. 2000 Jun 15;69(11):2243-50.

PMID:
10868621
10.

Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2-positive patients with acute myeloid leukemia.

Greiner J, Li L, Ringhoffer M, Barth TF, Giannopoulos K, Guillaume P, Ritter G, Wiesneth M, Döhner H, Schmitt M.

Blood. 2005 Aug 1;106(3):938-45. Epub 2005 Apr 12.

11.

Bone marrow transplantation from a pediatric donor with a high frequency of cytomegalovirus-specific T-cells.

Komatsu H, Kogawa K, Nonoyama S, Inui A, Sogo T, Fujisawa T, Klenerman P.

J Med Virol. 2006 Dec;78(12):1616-23.

PMID:
17063516
12.

Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.

Zorn E, Wang KS, Hochberg EP, Canning C, Alyea EP, Soiffer RJ, Ritz J.

Clin Cancer Res. 2002 Jul;8(7):2052-60.

13.

Cytomegalovirus-specific CD8(+) T cells targeting different HLA/peptide combinations correlate with protection but at different threshold frequencies.

Giest S, Grace S, Senegaglia AC, Pasquini R, Gonzalo-Daganzo RM, Fernández MN, Mackinnon S, Madrigal JA, Travers PJ.

Br J Haematol. 2010 Jan;148(2):311-22.

PMID:
20095088
14.

Persistent viral infection in humans can drive high frequency low-affinity T-cell expansions.

Khan N, Cobbold M, Cummerson J, Moss PA.

Immunology. 2010 Dec;131(4):537-48. doi: 10.1111/j.1365-2567.2010.03326.x. Epub 2010 Aug 16.

15.

Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.

Horowitz A, Guethlein LA, Nemat-Gorgani N, Norman PJ, Cooley S, Miller JS, Parham P.

J Immunol. 2015 Nov 1;195(9):4524-36. doi: 10.4049/jimmunol.1401990. Epub 2015 Sep 28.

16.

Ex vivo characterization of polyclonal memory CD8+ T-cell responses to PRAME-specific peptides in patients with acute lymphoblastic leukemia and acute and chronic myeloid leukemia.

Rezvani K, Yong AS, Tawab A, Jafarpour B, Eniafe R, Mielke S, Savani BN, Keyvanfar K, Li Y, Kurlander R, Barrett AJ.

Blood. 2009 Mar 5;113(10):2245-55. doi: 10.1182/blood-2008-03-144071. Epub 2008 Nov 6.

18.

In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naïve repertoire.

Ho WY, Nguyen HN, Wolfl M, Kuball J, Greenberg PD.

J Immunol Methods. 2006 Mar 20;310(1-2):40-52. Epub 2006 Jan 26.

PMID:
16469329
19.
20.

A comparison of gene transfer and antigen-loaded dendritic cells for the generation of CD4+ and CD8+ cytomegalovirus-specific T cells in HLA-A2+ and HLA-A2- donors.

Foster AE, Bradstock KF, Sili U, Marangolo M, Rooney CM, Gottlieb DJ.

Biol Blood Marrow Transplant. 2004 Nov;10(11):761-71.

Supplemental Content

Support Center